KEZAR LIFE SCIENCES INC (KZR) Fundamental Analysis & Valuation

NASDAQ:KZR • US49372L2097

Current stock price

7.39 USD
+0.02 (+0.27%)
Last:

This KZR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KZR Profitability Analysis

1.1 Basic Checks

  • KZR had negative earnings in the past year.
  • KZR had a negative operating cash flow in the past year.
  • KZR had negative earnings in each of the past 5 years.
  • KZR had a negative operating cash flow in each of the past 5 years.
KZR Yearly Net Income VS EBIT VS OCF VS FCFKZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • With a Return On Assets value of -73.11%, KZR is not doing good in the industry: 66.09% of the companies in the same industry are doing better.
  • KZR has a Return On Equity of -79.96%. This is comparable to the rest of the industry: KZR outperforms 48.84% of its industry peers.
Industry RankSector Rank
ROA -73.11%
ROE -79.96%
ROIC N/A
ROA(3y)-59.01%
ROA(5y)-44.98%
ROE(3y)-68.63%
ROE(5y)-51.78%
ROIC(3y)N/A
ROIC(5y)N/A
KZR Yearly ROA, ROE, ROICKZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KZR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KZR Yearly Profit, Operating, Gross MarginsKZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. KZR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for KZR has been increased compared to 1 year ago.
  • The number of shares outstanding for KZR has been reduced compared to 5 years ago.
  • KZR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KZR Yearly Shares OutstandingKZR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
KZR Yearly Total Debt VS Total AssetsKZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -5.17, we must say that KZR is in the distress zone and has some risk of bankruptcy.
  • KZR has a worse Altman-Z score (-5.17) than 63.95% of its industry peers.
  • There is no outstanding debt for KZR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.17
ROIC/WACCN/A
WACCN/A
KZR Yearly LT Debt VS Equity VS FCFKZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 11.52 indicates that KZR has no problem at all paying its short term obligations.
  • The Current ratio of KZR (11.52) is better than 83.72% of its industry peers.
  • KZR has a Quick Ratio of 11.52. This indicates that KZR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of KZR (11.52) is better than 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 11.52
Quick Ratio 11.52
KZR Yearly Current Assets VS Current LiabilitesKZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. KZR Growth Analysis

3.1 Past

  • KZR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.96%, which is quite impressive.
EPS 1Y (TTM)31.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.06% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y60.66%
EPS Next 2Y27.4%
EPS Next 3Y16.07%
EPS Next 5Y14.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KZR Yearly Revenue VS EstimatesKZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2029 2030 2031 2032 2033 100M 200M 300M
KZR Yearly EPS VS EstimatesKZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. KZR Valuation Analysis

4.1 Price/Earnings Ratio

  • KZR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year KZR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KZR Price Earnings VS Forward Price EarningsKZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KZR Per share dataKZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • KZR's earnings are expected to grow with 16.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.4%
EPS Next 3Y16.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KZR Dividend Analysis

5.1 Amount

  • No dividends for KZR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KZR Fundamentals: All Metrics, Ratios and Statistics

KEZAR LIFE SCIENCES INC

NASDAQ:KZR (4/13/2026, 2:33:58 PM)

7.39

+0.02 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-27
Earnings (Next)05-07
Inst Owners61.31%
Inst Owner Change0%
Ins Owners2.14%
Ins Owner Change0%
Market Cap54.46M
Revenue(TTM)N/A
Net Income(TTM)-56.03M
Analysts70
Price Target6.12 (-17.19%)
Short Float %2.94%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.39%
Min EPS beat(2)-59.88%
Max EPS beat(2)27.09%
EPS beat(4)3
Avg EPS beat(4)0.86%
Min EPS beat(4)-59.88%
Max EPS beat(4)27.09%
EPS beat(8)7
Avg EPS beat(8)6.03%
EPS beat(12)8
Avg EPS beat(12)2.6%
EPS beat(16)12
Avg EPS beat(16)4.31%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)13.86%
EPS NQ rev (3m)1.7%
EPS NY rev (1m)13.95%
EPS NY rev (3m)13.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-7.65
EYN/A
EPS(NY)-3.01
Fwd EYN/A
FCF(TTM)-7.03
FCFYN/A
OCF(TTM)-7.03
OCFYN/A
SpS0
BVpS9.51
TBVpS9.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.11%
ROE -79.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-59.01%
ROA(5y)-44.98%
ROE(3y)-68.63%
ROE(5y)-51.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.89%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.52
Quick Ratio 11.52
Altman-Z -5.17
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)57.82%
Cap/Depr(5y)69.91%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.34%
EPS Next Y60.66%
EPS Next 2Y27.4%
EPS Next 3Y16.07%
EPS Next 5Y14.06%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.23%
OCF growth 3YN/A
OCF growth 5YN/A

KEZAR LIFE SCIENCES INC / KZR Fundamental Analysis FAQ

What is the fundamental rating for KZR stock?

ChartMill assigns a fundamental rating of 2 / 10 to KZR.


What is the valuation status for KZR stock?

ChartMill assigns a valuation rating of 0 / 10 to KEZAR LIFE SCIENCES INC (KZR). This can be considered as Overvalued.


How profitable is KEZAR LIFE SCIENCES INC (KZR) stock?

KEZAR LIFE SCIENCES INC (KZR) has a profitability rating of 0 / 10.